Analyze Diet
Veterinary microbiology2006; 118(3-4); 255-259; doi: 10.1016/j.vetmic.2006.07.016

Characteristics of an outbreak of West Nile virus encephalomyelitis in a previously uninfected population of horses.

Abstract: Equine West Nile virus (WNV) encephalomyelitis cases - based on clinical signs and ELISA serology test results - reported to Texas disease control authorities during 2002 were analyzed to provide insights into the epidemiology of the disease within a previously disease-free population. The epidemic occurred between June 27 and December 17 (peaking in early October) and 1,698 cases were reported. Three distinct epidemic phases were identified, occurring mostly in southeast, northwest and then central Texas. Significant (P<0.05) disease clusters were identified in northwest and northern Texas. Most (91.1%) cases had no recent travel history, and most (68.9%) cases had not been vaccinated within the previous 12 months. One-third of cases did not survive, 71.2% of which were euthanatized. The most commonly reported presenting signs included ataxia (69%), abnormal gait (52%), muscle fasciculations (49%), depression (32%) and recumbency (28%). Vaccination status, ataxia, falling down, recumbency and lip droop best explained the risk of not surviving WNV disease. Results suggest that the peak risk period for encephalomyelitis caused by WNV may vary substantially among regions within Texas. Recumbent horses have a poor prognosis for survival. Vaccines, even if not administered sufficiently in advance of WNV infection within a district, may reduce the risk of death by at least 44%.
Publication Date: 2006-07-26 PubMed ID: 16971067DOI: 10.1016/j.vetmic.2006.07.016Google Scholar: Lookup
The Equine Research Bank provides access to a large database of publicly available scientific literature. Inclusion in the Research Bank does not imply endorsement of study methods or findings by Mad Barn.
  • Journal Article

Summary

This research summary has been generated with artificial intelligence and may contain errors and omissions. Refer to the original study to confirm details provided. Submit correction.

This research paper assesses and provides insight into an outbreak of West Nile virus (WNV) encephalomyelitis in a horse population in Texas during 2002 that had not been previously exposed to the virus. The study uncovers various aspects of the outbreak, including the phases of the epidemic, disease clusters, recent travel history of affected horses, vaccination status, survival rate, and commonly reported signs of the disease.

Epidemiological Analysis of WNV Encephalomyelitis Outbreak

This study undertakes a comprehensive analysis of equine West Nile virus (WNV) encephalomyelitis cases reported in Texas in 2002, which is based on clinical signs and ELISA serology tests.

  • The epidemic occurred between June 27 to December 17, peaking in early October and affecting around 1,698 horses.
  • The study identifies three distinct phases of the epidemic that majorly occurred in southeast, northwest, and central Texas.
  • Two significant disease clusters were identified in northwest and northern Texas.

Travel and Vaccination History of Affected Horses

The research also delves into the travel and vaccination history of the affected horses, as these factors could potentially influence the spread and severity of the disease.

  • It is noted that a majority (91.1%) of the horses afflicted by the disease had no recent travel history.
  • About 68.9% of the afflicted horses had not been vaccinated within the previous 12 months.

Survival Rate and Clinical Signs

The survival rate and the symptoms presented by afflicted horses were also scrutinized.

  • The study reports a low survival rate with one-third of the horses not surviving the outbreak.
  • The majority of the horses that died (71.2%) were actually euthanized.
  • The most common clinical signs observed in horses included ataxia (lack of muscle control – 69%), abnormal gait (52%), muscle fasciculations (involuntary muscle twitching – 49%), depression (32%), and recumbency (lying down – 28%).

Disease Risk Factors and Prognosis

In terms of risk factors and prognosis, the paper illustrates the impact of specific variables on disease progression and mortality.

  • Vaccination status, ataxia, falling down, recumbency and lip droop were found to have significant influence on the chances of a horse not surviving the disease.
  • The study also asserts the varying peak risk period for encephalomyelitis caused by WNV across different regions within Texas.
  • The prognosis for recumbent horses was observed to be poor.

Role of Vaccination

The role of vaccinations in potentially mitigating the risk of death was also examined.

  • Even if not administered adequately in advance of WNV infection within a district, vaccines were found to reduce the risk of death by at least 44%.

Cite This Article

APA
Ward MP, Schuermann JA, Highfield LD, Murray KO. (2006). Characteristics of an outbreak of West Nile virus encephalomyelitis in a previously uninfected population of horses. Vet Microbiol, 118(3-4), 255-259. https://doi.org/10.1016/j.vetmic.2006.07.016

Publication

ISSN: 0378-1135
NlmUniqueID: 7705469
Country: Netherlands
Language: English
Volume: 118
Issue: 3-4
Pages: 255-259

Researcher Affiliations

Ward, Michael P
  • Department of Veterinary Integrative Biosciences, MS 4458, Texas A&M University, College Station, TX 77843-4458, USA. mward@cvm.tamu.edu
Schuermann, James A
    Highfield, Linda D
      Murray, Kristy O

        MeSH Terms

        • Animals
        • Cluster Analysis
        • Disease Outbreaks / veterinary
        • Encephalomyelitis / epidemiology
        • Encephalomyelitis / mortality
        • Encephalomyelitis / veterinary
        • Encephalomyelitis / virology
        • Female
        • Geography
        • Horse Diseases / epidemiology
        • Horse Diseases / mortality
        • Horse Diseases / virology
        • Horses
        • Male
        • Prognosis
        • Risk Factors
        • Seasons
        • Texas / epidemiology
        • Time Factors
        • West Nile Fever / epidemiology
        • West Nile Fever / mortality
        • West Nile Fever / veterinary
        • West Nile Fever / virology
        • West Nile Virus Vaccines / administration & dosage
        • West Nile Virus Vaccines / immunology
        • West Nile virus / isolation & purification

        Citations

        This article has been cited 16 times.
        1. Bruno L, Nappo MA, Frontoso R, Perrotta MG, Di Lecce R, Guarnieri C, Ferrari L, Corradi A. West Nile Virus (WNV): One-Health and Eco-Health Global Risks. Vet Sci 2025 Mar 19;12(3).
          doi: 10.3390/vetsci12030288pubmed: 40266979google scholar: lookup
        2. García-Carrasco JM, Muñoz AR, Olivero J, Segura M, García-Bocanegra I, Real R. West Nile virus in the Iberian Peninsula: using equine cases to identify high-risk areas for humans. Euro Surveill 2023 Oct;28(40).
        3. Schwarz ER, Long MT. Comparison of West Nile Virus Disease in Humans and Horses: Exploiting Similarities for Enhancing Syndromic Surveillance. Viruses 2023 May 24;15(6).
          doi: 10.3390/v15061230pubmed: 37376530google scholar: lookup
        4. Fehér OE, Fehérvári P, Tolnai CH, Forgách P, Malik P, Jerzsele Á, Wagenhoffer Z, Szenci O, Korbacska-Kutasi O. Epidemiology and Clinical Manifestation of West Nile Virus Infections of Equines in Hungary, 2007-2020. Viruses 2022 Nov 18;14(11).
          doi: 10.3390/v14112551pubmed: 36423160google scholar: lookup
        5. Cavalleri JV, Korbacska-Kutasi O, Leblond A, Paillot R, Pusterla N, Steinmann E, Tomlinson J. European College of Equine Internal Medicine consensus statement on equine flaviviridae infections in Europe. J Vet Intern Med 2022 Nov;36(6):1858-1871.
          doi: 10.1111/jvim.16581pubmed: 36367340google scholar: lookup
        6. Ganzenberg S, Sieg M, Ziegler U, Pfeffer M, Vahlenkamp TW, Hörügel U, Groschup MH, Lohmann KL. Seroprevalence and Risk Factors for Equine West Nile Virus Infections in Eastern Germany, 2020. Viruses 2022 May 30;14(6).
          doi: 10.3390/v14061191pubmed: 35746662google scholar: lookup
        7. Stander J, Chabeda A, Rybicki EP, Meyers AE. A Plant-Produced Virus-Like Particle Displaying Envelope Protein Domain III Elicits an Immune Response Against West Nile Virus in Mice. Front Plant Sci 2021;12:738619.
          doi: 10.3389/fpls.2021.738619pubmed: 34589108google scholar: lookup
        8. Levasseur A, Arsenault J, Paré J. Surveillance of West Nile virus in horses in Canada: A retrospective study of cases reported to the Canadian Food Inspection Agency from 2003 to 2019. Can Vet J 2021 May;62(5):469-476.
          pubmed: 33967285
        9. Ronca SE, Ruff JC, Murray KO. A 20-year historical review of West Nile virus since its initial emergence in North America: Has West Nile virus become a neglected tropical disease?. PLoS Negl Trop Dis 2021 May;15(5):e0009190.
          doi: 10.1371/journal.pntd.0009190pubmed: 33956816google scholar: lookup
        10. Bertram FM, Thompson PN, Venter M. Epidemiology and Clinical Presentation of West Nile Virus Infection in Horses in South Africa, 2016-2017. Pathogens 2020 Dec 30;10(1).
          doi: 10.3390/pathogens10010020pubmed: 33396935google scholar: lookup
        11. Byas AD, Ebel GD. Comparative Pathology of West Nile Virus in Humans and Non-Human Animals. Pathogens 2020 Jan 7;9(1).
          doi: 10.3390/pathogens9010048pubmed: 31935992google scholar: lookup
        12. Venter M, Pretorius M, Fuller JA, Botha E, Rakgotho M, Stivaktas V, Weyer C, Romito M, Williams J. West Nile Virus Lineage 2 in Horses and Other Animals with Neurologic Disease, South Africa, 2008-2015. Emerg Infect Dis 2017 Dec;23(12):2060-2064.
          doi: 10.3201/eid2312.162078pubmed: 29148375google scholar: lookup
        13. Faverjon C, Andersson MG, Decors A, Tapprest J, Tritz P, Sandoz A, Kutasi O, Sala C, Leblond A. Evaluation of a Multivariate Syndromic Surveillance System for West Nile Virus. Vector Borne Zoonotic Dis 2016 Jun;16(6):382-90.
          doi: 10.1089/vbz.2015.1883pubmed: 27159212google scholar: lookup
        14. Marka A, Diamantidis A, Papa A, Valiakos G, Chaintoutis SC, Doukas D, Tserkezou P, Giannakopoulos A, Papaspyropoulos K, Patsoula E, Badieritakis E, Baka A, Tseroni M, Pervanidou D, Papadopoulos NT, Koliopoulos G, Tontis D, Dovas CI, Billinis C, Tsakris A, Kremastinou J, Hadjichristodoulou C, Vakalis N, Vassalou E, Zarzani S, Zounos A, Komata K, Balatsos G, Beleri S, Mpimpa A, Papavasilopoulos V, Rodis I, Spanakos G, Tegos N, Spyrou V, Dalabiras Z, Birtsas P, Athanasiou L, Papanastassopoulou M, Ioannou C, Athanasiou C, Gerofotis C, Papadopoulou E, Testa T, Tsakalidou O, Rachiotis G, Bitsolas N, Mamouris Z, Moutou K, Sarafidou T, Stamatis K, Sarri K, Tsiodras S, Georgakopoulou T, Detsis M, Mavrouli M, Stavropoulou A, Politi L, Mageira G, Christopoulou V, Diamantopoulou G, Spanakis N, Vrioni G, Piperaki ET, Mitsopoulou K, Kioulos I, Michaelakis A, Stathis I, Tselentis I, Psaroulaki A, Keramarou M, Chochlakis D, Photis Y, Konstantinou M, Manetos P, Tsobanoglou S, Mourelatos S, Antalis V, Pergantas P, Eleftheriou G. West Nile virus state of the art report of MALWEST Project. Int J Environ Res Public Health 2013 Dec 2;10(12):6534-610.
          doi: 10.3390/ijerph10126534pubmed: 24317379google scholar: lookup
        15. Martín-Acebes MA, Saiz JC. West Nile virus: A re-emerging pathogen revisited. World J Virol 2012 Apr 12;1(2):51-70.
          doi: 10.5501/wjv.v1.i2.51pubmed: 24175211google scholar: lookup
        16. Venter M, Human S, Zaayman D, Gerdes GH, Williams J, Steyl J, Leman PA, Paweska JT, Setzkorn H, Rous G, Murray S, Parker R, Donnellan C, Swanepoel R. Lineage 2 west nile virus as cause of fatal neurologic disease in horses, South Africa. Emerg Infect Dis 2009 Jun;15(6):877-84.
          doi: 10.3201/eid1506.081515pubmed: 19523285google scholar: lookup